BC
PFE icon

Bridgefront Capital’s Pfizer PFE Stock Holding History

Bridgefront Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-114,653
Closed -$2.85M – 710
2025
Q4 		$2.85M Buy
+114,653
New +$2.89M 0.72% 14
2025
Q3 		– Sell
-24,496
Closed -$594K – 770
2025
Q2 		$594K Sell
24,496
-67,775
-73% -$1.58M 0.16% 237
2025
Q1 		$2.34M Buy
92,271
+64,402
+231% +$1.69M 0.68% 7
2024
Q4 		$739K Sell
27,869
-8,594
-24% -$233K 0.25% 118
2024
Q3 		$1.06M Sell
36,463
-38,318
-51% -$1.12M 0.41% 44
2024
Q2 		$2.09M Buy
74,781
+52,419
+234% +$1.44M 0.87% 7
2024
Q1 		$621K Sell
22,362
-247
-1% -$6.85K 0.47% 43
2023
Q4 		$651K Sell
22,609
-5,756
-20% -$174K 0.49% 41
2023
Q3 		$941K Buy
28,365
+20,683
+269% +$731K 0.66% 18
2023
Q2 		$282K Buy
7,682
+1,814
+31% +$70.6K 0.15% 270
2023
Q1 		$239K Buy
+5,868
New +$253K 0.15% 280
2021
Q4 		– Sell
-9,167
Closed -$394K – 416
2021
Q3 		$394K Buy
+9,167
New +$406K 0.41% 74
2021
Q1 		– Sell
-37,822
Closed -$1.39M – 856
2020
Q4 		$1.39M Buy
+37,822
New +$1.39M 0.48% 20

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bridgefront Capital's PFE Position: Q1 2026 in Review

Bridgefront Capital sold out of Pfizer (PFE) in Q1 2026, closing a stake of 114,653 shares — an estimated $2.85M sold.

Bridgefront Capital first reported a position in PFE in Q4 2020 and held it in 13 quarters. The position peaked at $2.85M in Q4 2025. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bridgefront Capital reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Bridgefront Capital sold 114,653 Pfizer shares in Q1 2026, an estimated $2.85M.
  • Bridgefront Capital first reported a position in Pfizer in Q4 2020 and held it in 13 quarters.
  • Bridgefront Capital's Pfizer position peaked at $2.85M in Q4 2025.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.